علاج مرض بهجت مع الإصابة البرنشيمية للجهاز العصبي المركزي

References

DOI: 10.1136/annrheumdis-2018-213225

• Acute attacks of parenchymal involvement should be treated with high-dose glucocorticoids followed by slow tapering, together with immunosuppressives such as azathioprine.
• Monoclonal anti-TNF antibodies should be considered in severe disease as first line or in refractory patients.
• Patients who have severe parenchymal involvement at onset, those who have persistent or relapsing disease despite corticosteroids and azathioprine and patients with chronic progressive nervous system involvement that is a more severe form of parenchymal involvement may benefit from monoclonal anti-TNF antibodies.